title: Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening.
abstract: Flutamide (FLU) is an antiandrogen primarily used in the treatment of metastatic prostate cancer. It is an idiosyncratic hepatotoxicant that sometimes results in severe liver toxicity. FLU possesses a nitroaromatic group, which may be a contributor to its mechanism of toxicity. A nitro to cyano analogue of FLU (CYA) was synthesized and used to test this hypothesis in the TGFalpha-transfected mouse hepatocyte cell line (TAMH). MTT cell viability assays and confocal microscopy showed that hepatocytes are more sensitive to cytotoxicity caused by FLU than CYA (LD 50 75 vs 150 microM, respectively). Despite the structural modification, the antiandrogen activity of CYA is comparable to that of FLU. Comparisons of transcriptomic changes caused by FLU with those caused by a panel of known cytotoxicants [acetaminophen, tetrafluoroethylcysteine, diquat, and rotenone (ROT)] indicated that FLU results in a temporal gene expression pattern similar to ROT, a known inhibitor of complex I of the electron transport chain. A subsequent microarray analysis comparing FLU to CYA and ROT revealed many similarities among these three compounds; however, FLU and ROT result in more substantial changes than CYA in the expression of genes associated with oxidative phosphorylation, fatty acid beta-oxidation, antioxidant defense, and cell death pathways. Electron microscopy confirmed that FLU leads to mitochondrial toxicity that has some similarities to the mitochondrial effects of ROT, but the morphologic changes caused by FLU were greater in scope with both intra- and intercellular manifestations. Biochemical studies confirmed that both ROT and FLU deplete cellular ATP levels and inhibit complex I of the electron transport chain to a greater extent than CYA. Thus, as compared to CYA, the nitroaromatic group of FLU enhances cytotoxicity to hepatocytes, likely through mechanisms involving mitochondrial dysfunction and ATP depletion that include complex I inhibition.
authors: Department of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA.
authors: Kevin J
authors: KJ
authors: Coe
authors: Yankai
authors: Y
authors: Jia
authors: Han Kiat
authors: HK
authors: Ho
authors: Peter
authors: P
authors: Rademacher
authors: Theo K
authors: TK
authors: Bammler
authors: Richard P
authors: RP
authors: Beyer
authors: Frederico M
authors: FM
authors: Farin
authors: Libby
authors: L
authors: Woodke
authors: Stephen R
authors: SR
authors: Plymate
authors: Nelson
authors: N
authors: Fausto
authors: Sidney D
authors: SD
authors: Nelson
mesh_terms: D000255:Adenosine Triphosphate / Q000032:analysis / Q000378:metabolism; D000726:Androgen Antagonists / Q000494:pharmacology; D000818:Animals; D045744:Cell Line, Tumor; D002470:Cell Survival; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor; D042967:Electron Transport Complex I / Q000037:antagonists & inhibitors* / Q000187:drug effects / Q000235:genetics; D005485:Flutamide / Q000737:chemistry* / Q000494:pharmacology*; D005786:Gene Expression Regulation; D022781:Hepatocytes / Q000187:drug effects* / Q000648:ultrastructure; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D046228:Microarray Analysis; D008928:Mitochondria / Q000187:drug effects*; D015394:Molecular Structure; D009570:Nitriles / Q000737:chemistry* / Q000494:pharmacology; D009574:Nitro Compounds / Q000737:chemistry* / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000726:Androgen Antagonists; D009570:Nitriles; D009574:Nitro Compounds; D005485:Flutamide; D000255:Adenosine Triphosphate; D042967:Electron Transport Complex I
references: Life Sci. 2001 Dec 14;70(4):471-82
references: 11798015
references: Toxicol Appl Pharmacol. 2007 Apr 1;220(1):92-107
references: 17275868
references: Drug Metab Dispos. 2006 May;34(5):828-35
references: 16507648
references: Genome Biol. 2003;4(10):R70
references: 14519205
references: Expert Opin Drug Metab Toxicol. 2005 Jun;1(1):75-90
references: 16922654
references: J Biol Chem. 2003 Nov 28;278(48):48292-9
references: 14500711
references: J Pharmacol Exp Ther. 2003 Oct;307(1):1-8
references: 12954806
references: J Urol. 1996 Jan;155(1):209-12
references: 7490837
references: Rev Esp Enferm Dig. 2001 Jul;93(7):423-32
references: 11685939
references: Res Commun Chem Pathol Pharmacol. 1980 Jun;28(3):447-56
references: 7403659
references: Mol Carcinog. 2005 Dec;44(4):242-51
references: 16240454
references: Biochem Pharmacol. 1995 Sep 28;50(7):1113-9
references: 7575670
references: Cancer Res. 1994 Nov 15;54(22):5964-73
references: 7525051
references: Drug Saf. 2002;25(9):633-48
references: 12137558
references: Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5205-10
references: 17360324
references: Cancer Res. 1989 Aug 15;49(16):4435-40
references: 2743332
references: Prostate. 2006 Aug 1;66(11):1177-93
references: 16652386
references: Life Sci. 2006 May 15;78(25):2889-97
references: 16378625
references: Genome Biol. 2001;2(11):SOFTWARE0002
references: 16173164
references: Curr Opin Drug Discov Devel. 2003 Jan;6(1):81-91
references: 12613279
references: Biochem Pharmacol. 1996 Oct 25;52(8):1147-54
references: 8937421
references: Hepatology. 2003 Jan;37(1):136-47
references: 12500198
references: Bioinformatics. 2003 Jan 22;19(2):185-93
references: 12538238
references: Hepatology. 2003 Oct;38(4):1053-5
references: 14567386
references: Drug Metab Dispos. 2007 Jul;35(7):1081-8
references: 17403914
references: J Pharmacol Exp Ther. 1994 Jun;269(3):954-62
references: 8014883
references: Curr Opin Allergy Clin Immunol. 2003 Aug;3(4):235-42
references: 12865765
references: Biochem Pharmacol. 2002 Aug 1;64(3):413-24
references: 12147292
references: J Pharmacol Exp Ther. 1991 May;257(2):714-9
references: 1851835
references: Genome Biol. 2004;5(10):R80
references: 15461798
references: Curr Drug Metab. 2003 Aug;4(4):292-312
references: 12871046
references: Biochemistry. 1975 Apr 22;14(8):1626-32
references: 164892
references: J Pharmacol Exp Ther. 1993 Apr;265(1):366-72
references: 8386241
references: Drug Discov Today. 2003 Sep 15;8(18):832-7
references: 12963319
references: Biochim Biophys Acta. 1969 Feb 25;172(2):331-3
references: 4304726
references: Arch Biochem Biophys. 2006 Oct 1;454(1):7-15
references: 16962985
references: J Biol Chem. 1989 Jun 15;264(17):9814-9
references: 2524496
references: Stat Appl Genet Mol Biol. 2004;3:Article3
references: 16646809
references: Toxicol Lett. 2003 Mar 20;139(1):67-75
references: 12595159
references: Toxicol Lett. 1992 Jul;61(2-3):275-81
references: 1641873
references: J Pharmacol Exp Ther. 1994 Jul;270(1):167-76
references: 8035313
references: Am J Med. 1992 May;92(5):465-70
references: 1349790
references: Genome Biol. 2003;4(5):P3
references: 12734009
references: Prostate. 2004 Nov 1;61(3):276-90
references: 15368471
references: Curr Drug Metab. 2006 Oct;7(7):715-27
references: 17073576
references: Drug Metab Rev. 2004 Oct;36(3-4):805-22
references: 15554248
references: Drug Metab Dispos. 2006 Jun;34(6):984-92
references: 16540588
references: Biochemistry. 2002 May 28;41(21):6789-97
references: 12022883
references: Drug Metab Dispos. 2001 Feb;29(2):141-4
references: 11159803
references: Toxicol Lett. 2001 Mar 31;120(1-3):359-68
references: 11323195
references: Arch Toxicol. 2001 Sep;75(7):425-38
references: 11693184
references: Drug Metab Rev. 2006;38(4):769-89
references: 17145701
references: Nat Methods. 2005 May;2(5):351-6
references: 15846362
references: Toxicol Sci. 2000 Feb;53(2):340-51
references: 10696782
references: Pharmacol Toxicol. 2003 Sep;93(3):105-15
references: 12969434
references: Chem Biol Interact. 2002 Nov 10;142(1-2):7-23
references: 12399152
references: Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1301-11
references: 16836974
references: Chem Res Toxicol. 2006 Mar;19(3):480-90
references: 16544956
references: Drug Metab Dispos. 2006 Jul;34(7):1266-75
references: 16611858
references: Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):253-9
references: 16294367
references: J Biol Chem. 2004 Sep 17;279(38):39846-55
references: 15247300